HT
TEVA icon

HAP Trading’s Teva Pharmaceuticals TEVA Stock Holding History

HAP Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$293K Buy
+14,492
New +$255K 0.02% 341
2024
Q1 		– Sell
-26,945
Closed -$281K – 1046
2023
Q4 		$281K Sell
26,945
-10,274
-28% -$95.9K 0.04% 253
2023
Q3 		$380K Buy
37,219
+3,739
+11% +$34.8K 0.06% 233
2023
Q2 		$252K Sell
33,480
-16,524
-33% -$134K 0.04% 264
2023
Q1 		$443K Sell
50,004
-203,913
-80% -$2.02M 0.07% 207
2022
Q4 		$2.32M Buy
253,917
+42,500
+20% +$371K 0.24% 105
2022
Q3 		$1.71M Sell
211,417
-4,159
-2% -$36.8K 0.11% 171
2022
Q2 		$1.62M Buy
215,576
+135,259
+168% +$1.18M 0.08% 204
2022
Q1 		$754K Buy
80,317
+14,192
+21% +$118K 0.03% 421
2021
Q4 		$530K Sell
66,125
-10,108
-13% -$91.2K 0.01% 661
2021
Q3 		$743K Sell
76,233
-16,630
-18% -$156K 0.02% 552
2021
Q2 		$919K Buy
+92,863
New +$983K 0.03% 483
2021
Q1 		– Sell
-93,844
Closed -$906K – 2355
2020
Q4 		$906K Buy
+93,844
New +$899K 0.03% 441
2020
Q3 		– Sell
-126,533
Closed -$1.56M – 1884
2020
Q2 		$1.56M Buy
+126,533
New +$1.43M 0.09% 208
2019
Q2 		– Sell
-176,092
Closed -$2.12M – 1336
2019
Q1 		$2.76M Buy
+176,092
New +$3.11M 0.25% 83
2018
Q2 		– Sell
-40,984
Closed -$836K – 1120
2018
Q1 		$700K Sell
40,984
-20,960
-34% -$409K 0.04% 278
2017
Q4 		$1.17M Buy
61,944
+25,660
+71% +$386K 0.05% 255
2017
Q3 		$639K Buy
+36,284
New +$816K 0.03% 325
2017
Q2 		– Sell
-16,101
Closed -$498K – 1151
2017
Q1 		$517K Buy
+16,101
New +$549K 0.03% 330
2016
Q4 		– Sell
-13,392
Closed -$535K – 1207
2016
Q3 		$616K Sell
13,392
-108,424
-89% -$5.66M 0.02% 337
2016
Q2 		$6.12M Buy
+121,816
New +$6.49M 0.36% 55
2015
Q4 		– Sell
-40,030
Closed -$2.47M – 1102
2015
Q3 		$2.26M Sell
40,030
-174,714
-81% -$11.3M 0.12% 170
2015
Q2 		$12.7M Buy
214,744
+23,205
+12% +$1.43M 0.77% 28
2015
Q1 		$11.9M Sell
191,539
-2,054,355
-91% -$119M 0.81% 32
2014
Q4 		$129M Buy
2,245,894
+738,393
+49% +$41.1M 4.78% 2
2014
Q3 		$81M Buy
1,507,501
+397,500
+36% +$21.1M 3.2% 3
2014
Q2 		$58.2M Buy
1,110,001
+821,100
+284% +$42M 2.15% 5
2014
Q1 		$15.3M Sell
288,901
-174,911
-38% -$8.08M 0.69% 25
2013
Q4 		$18.6M Buy
463,812
+105,352
+29% +$4.15M 0.58% 34
2013
Q3 		$13.5M Buy
358,460
+41,698
+13% +$1.63M 0.43% 50
2013
Q2 		$12.4M Buy
+316,762
New +$12.3M 0.42% 52

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

HAP Trading's TEVA Position: Q3 2025 in Review

HAP Trading opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2025: 14,492 shares worth $293K. The stake represents 0.02% of the portfolio and ranks #341 among its holdings. This is a return to the name: HAP Trading previously reported a position in TEVA as recently as Q4 2023.

HAP Trading first reported a position in TEVA in Q2 2013 and has held it in 31 quarters since. The position peaked at $129M in Q4 2014. 551 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • HAP Trading held 14,492 shares of Teva Pharmaceuticals worth $293K as of Q3 2025.
  • Teva Pharmaceuticals was a new HAP Trading position in Q3 2025.
  • Teva Pharmaceuticals made up 0.02% of HAP Trading's portfolio in Q3 2025, its #341 holding.
  • HAP Trading first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 31 quarters since.
  • HAP Trading's Teva Pharmaceuticals position peaked at $129M in Q4 2014.
  • 551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.